Vivaldi Capital Management LP Galectin Therapeutics Inc Transaction History
Vivaldi Capital Management LP
- $653 Million
- Q2 2025
A detailed history of Vivaldi Capital Management LP transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Vivaldi Capital Management LP holds 172,443 shares of GALT stock, worth $650,110. This represents 0.06% of its overall portfolio holdings.
Number of Shares
172,443
Previous 55,628
209.99%
Holding current value
$650,110
Previous $67,000
441.79%
% of portfolio
0.06%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding GALT
# of Institutions
96Shares Held
11.1MCall Options Held
136KPut Options Held
370K-
Vanguard Group Inc Valley Forge, PA2.18MShares$8.24 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$5.9 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.19MShares$4.49 Million0.01% of portfolio
-
Jane Street Group, LLC New York, NY749KShares$2.82 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA666KShares$2.51 Million0.0% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $224M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...